Aadhaar Ventures India Ltd
Aadhaar Ventures India is an India-based investment company. The Company is a non-deposit accepting non-banking finance company (NBFC). The Company is engaged in finance, investment and trading in shares and securities. The Company's activities include financing periodical loans, equity participation, supervisory and consultancy services, leasing and bill discounting.
- Market Cap ₹ 7.70 Cr.
- Current Price ₹ 0.49
- High / Low ₹ /
- Stock P/E
- Book Value ₹ 23.3
- Dividend Yield 0.00 %
- ROCE 0.01 %
- ROE 0.01 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Stock is trading at 0.02 times its book value
Cons
- Company has a low return on equity of -0.15% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 16.36 | 22.26 | 17.42 | 9.19 | 9.23 | 0.90 | 0.00 | 0.05 | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 |
| 16.73 | 21.74 | 17.42 | 9.11 | 9.29 | 1.11 | 0.20 | 0.11 | 0.05 | 0.16 | 1.89 | 0.15 | 0.07 | |
| Financing Profit | -0.37 | 0.52 | 0.00 | 0.08 | -0.06 | -0.21 | -0.20 | -0.06 | -0.01 | -0.17 | -1.89 | -0.15 | -0.07 |
| Financing Margin % | -2.26% | 2.34% | 0.00% | 0.87% | -0.65% | -23.33% | -120.00% | -25.00% | |||||
| 0.76 | 0.00 | 0.32 | -0.16 | 0.13 | 0.03 | 0.02 | 0.03 | 0.03 | 0.18 | 0.18 | 0.17 | 0.07 | |
| Depreciation | 0.05 | 0.05 | 0.05 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 0.34 | 0.47 | 0.27 | -0.08 | 0.07 | -0.18 | -0.18 | -0.03 | 0.01 | 0.01 | -1.71 | 0.02 | 0.00 |
| Tax % | 29.41% | 31.91% | 25.93% | 50.00% | 14.29% | 22.22% | 0.00% | 33.33% | 600.00% | 0.00% | 0.58% | 0.00% | |
| 0.23 | 0.32 | 0.21 | -0.12 | 0.05 | -0.23 | -0.18 | -0.04 | -0.04 | 0.01 | -1.71 | 0.02 | 0.00 | |
| EPS in Rs | 0.01 | 0.02 | 0.01 | -0.01 | 0.00 | -0.01 | -0.01 | -0.00 | -0.00 | 0.00 | -0.11 | 0.00 | 0.00 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -24% |
| 5 Years: | 16% |
| 3 Years: | 36% |
| TTM: | -100% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -9% |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| Last Year: | 0% |
Balance Sheet
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 157.10 | 157.10 | 157.10 | 157.10 | 157.10 | 157.10 | 157.10 | 157.10 | 157.10 | 157.10 | 157.10 | 157.10 | 157.10 |
| Reserves | 454.31 | 210.92 | 211.12 | 211.00 | 211.05 | 210.82 | 210.64 | 210.61 | 210.57 | 210.57 | 208.75 | 208.77 | 208.77 |
| Borrowing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 69.46 | 315.20 | 287.75 | 266.61 | 145.65 | 62.71 | 62.81 | 55.05 | 52.77 | 9.87 | 1.16 | 0.36 | 0.36 | |
| Total Liabilities | 680.87 | 683.22 | 655.97 | 634.71 | 513.80 | 430.63 | 430.55 | 422.76 | 420.44 | 377.54 | 367.01 | 366.23 | 366.23 |
| 0.11 | 0.07 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 179.15 | 106.18 | 55.50 | 159.06 | 153.55 | 153.55 | 153.55 | 153.55 | 156.94 | 156.94 | 156.83 | 156.83 | 156.83 |
| 501.61 | 576.97 | 600.45 | 475.64 | 360.24 | 277.07 | 276.99 | 269.20 | 263.50 | 220.60 | 210.18 | 209.40 | 209.40 | |
| Total Assets | 680.87 | 683.22 | 655.97 | 634.71 | 513.80 | 430.63 | 430.55 | 422.76 | 420.44 | 377.54 | 367.01 | 366.23 | 366.23 |
Cash Flows
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -117.19 | 240.62 | -28.65 | 43.44 | 3.57 | -3.48 | -0.24 | -0.29 | -0.64 | -41.55 | -8.85 | 0.04 | |
| 43.13 | 73.26 | 51.00 | -103.58 | 5.56 | 0.00 | 0.00 | 0.05 | -3.36 | 0.00 | 0.12 | 0.00 | |
| 73.75 | -314.15 | -22.35 | 61.24 | -10.24 | 3.48 | 0.24 | 0.25 | 4.04 | 41.56 | 8.81 | 0.03 | |
| Net Cash Flow | -0.31 | -0.27 | 0.00 | 1.10 | -1.11 | 0.00 | 0.00 | 0.01 | 0.03 | 0.01 | 0.07 | 0.07 |
Ratios
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE % | 0.03% | 0.06% | 0.05% | -0.03% | 0.00% | -0.06% | -0.05% | -0.01% | -0.01% | 0.00% | -0.47% | 0.01% |
Insights
In beta| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
|---|---|---|---|---|---|---|---|---|---|
| Employee Benefit Expenses INR Lakhs |
|
||||||||
| Trading Volume (Turnover) INR Lakhs |
|||||||||
| Loan Book (Long-term Loans and Advances) INR |
|||||||||
| Non-Current Investments (Investment Portfolio) INR |
|||||||||
Documents
Announcements
- Closure of Trading Window 9h
-
Board Meeting Outcome for Independent Directors Meeting
20 Mar - Independent directors met on 20 Mar 2026; reviewed board, chairperson performance and information flow; meeting 02:00-02:30 PM.
-
Board Meeting Intimation for Independent Directors Meeting
11 Mar - Independent Directors meeting on 20 March 2026 to review board, chairman performance and information flow.
-
Un-Audited Financial Results (UFR) For The Third Quarter And Nine Months Ended December 31, 2025.
14 Feb - Board approved unaudited Q3 and nine-month results for Dec 31, 2025; limited review delayed due to auditor's medical condition
-
Board Meeting Outcome for Un-Audited Financial Results (UFR) For The Third Quarter And Nine Months Ended December 31, 2025 Along With The Statutory Auditors'' Limited Review Report
14 Feb - Board approved unaudited results for quarter and nine months ended Dec 31, 2025; limited review delayed due to auditor illness.
Annual reports
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse